世界の経皮的血管形成術用バルーン市場：医療機器パイプライン分析2016...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Percutaneous Transluminal Angioplasty Balloons Overview 6
3 Products under Development 7
3.1 Percutaneous Transluminal Angioplasty Balloons – Pipeline Products by Stage of Development 7
3.2 Percutaneous Transluminal Angioplasty Balloons – Pipeline Products by Territory 8
3.3 Percutaneous Transluminal Angioplasty Balloons – Pipeline Products by Regulatory Path 9
3.4 Percutaneous Transluminal Angioplasty Balloons – Pipeline Products by Estimated Approval Date 10
3.5 Percutaneous Transluminal Angioplasty Balloons – Ongoing Clinical Trials 11
4 Percutaneous Transluminal Angioplasty Balloons – Pipeline Products under Development by Companies 12
4.1 Percutaneous Transluminal Angioplasty Balloons Companies – Pipeline Products by Stage of Development 12
4.2 Percutaneous Transluminal Angioplasty Balloons – Pipeline Products by Stage of Development 13
5 Percutaneous Transluminal Angioplasty Balloons Companies and Product Overview 14
5.1 Andramed GmbH Company Overview 14
5.1.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Arravasc Limited Company Overview 16
5.2.1 Arravasc Limited Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 Boston Scientific Corporation Company Overview 18
5.3.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 Contego Medical, LLC Company Overview 20
5.4.1 Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.5 MicroPort Scientific Corporation Company Overview 24
5.5.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 24
5.6 Occlutech International AB Company Overview 27
5.6.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 QT Vascular Ltd. Company Overview 29
5.7.1 QT Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 29
5.8 SurModics, Inc. Company Overview 33
5.8.1 SurModics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.9 Terumo Corporation Company Overview 37
5.9.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 37
6 Percutaneous Transluminal Angioplasty Balloons- Recent Developments 39
6.1 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 39
6.2 Apr 21, 2016: AV Medical Announces Successful Completion of 30 Patient Study with its Innovative Angioplasty Balloon Catheter, Chameleon 39
6.3 Apr 13, 2016: STENTYS Reports 38% Increase in Revenues in First Quarter 2016 40
6.4 Mar 16, 2016: STENTYS Reports 2015 Annual Results 40
6.5 Feb 19, 2016: Nipro Medical Corporation launches the Cronus HP 0.035″ OTW PTA Balloon Catheter in the United States 41
6.6 Feb 12, 2016: Stentys Raises USD14.3 Million in Rights Offering of Shares 41
6.7 Feb 09, 2016: New Real-World Comparison Showing Similar Efficacy Between the Lutonix and In.Pact Drug-Coated Balloons Featured at LINC 2016 42
6.8 Jan 26, 2016: Contego Medical Announces Positive Clinical Data for Paladin System, the First Post-Dilation Balloon with Integrated Embolic Protection Technology 43
6.9 Jan 13, 2016: STENTYS Reports 81% Year-over-Year Growth in Fourth-Quarter 2015 Revenues 43
6.10 Jan 11, 2016: SurModics Acquires NorMedix for USD14 Million 44
6.11 Jan 04, 2016: NuCryo Vascular Gets FDA 510(k) Approval For Next-generation Cryoplasty Inflation Device 44
6.12 Dec 28, 2015: Registration of Dongguan Kewei Occluder Series Products in Kazakhstan Approved 44
6.13 Dec 23, 2015: MicroPort Completed the First Distant Interactive Surgery in the Field of Coronary Interventional Treatment 45
6.14 Dec 02, 2015: MicroPort Orthopedics Attend the Tenth Session of the COA International Conference 45
6.15 Nov 03, 2015: Additional First Time Endovascular Clinical Trial Results Announced At VIVA15 47
6.16 Oct 15, 2015: STENTYS Reports 84% Growth in Third-Quarter 2015 Revenues 48
6.17 Oct 12, 2015: Lutonix Global Real-World Registry Outcomes Presented at TCT 2015 48
6.18 Sep 30, 2015: QT Vascular Announces Positive Outcome in Spectranetics/AngioScore Patent Trial 49
6.19 Sep 17, 2015: STENTYS Reports First Half 2015 Financial Results 49
6.20 Sep 09, 2015: MicroPort Scientific Corporation Announce Leadership Changes in MicroPort Orthopedics Subsidiary and Membership Changes in CEC, IEC 49
6.21 Sep 01, 2015: MPSC New COO Appointment – Jason Zhang 51
6.22 Aug 31, 2015: Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 51
6.23 Aug 03, 2015: CMS Approves Add-on Payment for Lutonix Drug-Coated Balloon for Inpatient Use 52
6.24 Jul 14, 2015: QT Vascular Announces The Allowance Of Four New Patents 52
6.25 Jul 08, 2015: QT Vascular – AngioScore Litigation Additional Updates 53
6.26 Jul 08, 2015: STENTYS Reports 40% Increase in Revenues in Second Quarter of 2015 55
6.27 Jun 24, 2015: Spectranetics Receives FDA 510(k) Clearance for Larger Diameter AngioSculpt Scoring Balloon Enabling Entry Into New Markets 56
6.28 Jun 24, 2015: Premier showcases medical innovations designed to improve patient care 56
6.29 Jun 02, 2015: Re-inflating balloon after carotid stenting appears to double risk of stroke and death 57
7 Appendix 59
7.1 Methodology 59
7.2 About GlobalData 61
7.3 Contact Us 62
7.4 Disclaimer 62